Cargando…

2147. Human Infections due to Actinotignum Species: A 5-Year Retrospective Review at Mayo Clinic Rochester, Minnesota

BACKGROUND: We aim to investigate the incidence, clinical presentation, management, and outcome of infections due to Actinotignum species observed at Mayo Clinic Rochester over the last 5 years. METHODS: We searched the clinical microbiology laboratory database to identify isolates of Actinotignum s...

Descripción completa

Detalles Bibliográficos
Autores principales: Syed, Sadia, Sohail, Muhammad R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809726/
http://dx.doi.org/10.1093/ofid/ofz360.1827
_version_ 1783462066351243264
author Syed, Sadia
Sohail, Muhammad R
author_facet Syed, Sadia
Sohail, Muhammad R
author_sort Syed, Sadia
collection PubMed
description BACKGROUND: We aim to investigate the incidence, clinical presentation, management, and outcome of infections due to Actinotignum species observed at Mayo Clinic Rochester over the last 5 years. METHODS: We searched the clinical microbiology laboratory database to identify isolates of Actinotignum spp. from all body sites between January 1, 2014 and December 31, 2018. RESULTS: Fifty-four patients with positive culture with Actinotignum were identified. Mean age was 67 years and 27 (50%) had an underlying urogenital condition. Actinotignum was isolated in 26 urine cultures, 6 blood cultures, 12 abscess fluid cultures, and 10 bone/joint tissue cultures (Table 1). Fifteen (28%) specimens were monomicrobial while 39 (72%) were polymicrobial. Recovery from urine cultures was interpreted as colonization in 11 (20%) cases. Of the 54 patients with positive cultures, 43 patients had Actinotignum-associated clinical infection; 15 (35%) with urinary tract infections (11 with cystitis and 4 with pyelonephritis), 12 (28%) with abscesses (skin, intraabdominal, and surgical site infections), 10 (23%) with bone/joint infection, and 6 (14%) with bacteremia (Table 2). Most frequently isolated species was A. schaalii (n = 40); followed by 2 cases of A. sanguinis. Susceptibility testing (n = 40) showed that all stains were susceptible to penicillin (MIC< = 0.5), 36% were susceptible to clindamycin (MIC < = 2) and 10% susceptible to metronidazole (MIC < = 8). There was no recurrence of Actinotignum-related infections in any of the treated cases. Two patients with bone/joint infection underwent repeat surgical intervention due to worsening infection while on antibiotic treatment prior to resolution of infection. There was 1 death in a patient with bacteremia (polymicrobial) who had presented with a massive stroke (Table 3). CONCLUSION: A. schaalii was most commonly associated with urinary tract infections followed by abscesses and bone/joint infections in elderly population. Majority of the infections were polymicrobial. All tested isolated were susceptible to penicillin; however, resistance was frequent for clindamycin and metronidazole. All appropriately treated patients had resolution of infection without recurrence from Actinotignum, except for one patient with bacteremia who died from massive stroke [Image: see text] [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6809726
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68097262019-10-28 2147. Human Infections due to Actinotignum Species: A 5-Year Retrospective Review at Mayo Clinic Rochester, Minnesota Syed, Sadia Sohail, Muhammad R Open Forum Infect Dis Abstracts BACKGROUND: We aim to investigate the incidence, clinical presentation, management, and outcome of infections due to Actinotignum species observed at Mayo Clinic Rochester over the last 5 years. METHODS: We searched the clinical microbiology laboratory database to identify isolates of Actinotignum spp. from all body sites between January 1, 2014 and December 31, 2018. RESULTS: Fifty-four patients with positive culture with Actinotignum were identified. Mean age was 67 years and 27 (50%) had an underlying urogenital condition. Actinotignum was isolated in 26 urine cultures, 6 blood cultures, 12 abscess fluid cultures, and 10 bone/joint tissue cultures (Table 1). Fifteen (28%) specimens were monomicrobial while 39 (72%) were polymicrobial. Recovery from urine cultures was interpreted as colonization in 11 (20%) cases. Of the 54 patients with positive cultures, 43 patients had Actinotignum-associated clinical infection; 15 (35%) with urinary tract infections (11 with cystitis and 4 with pyelonephritis), 12 (28%) with abscesses (skin, intraabdominal, and surgical site infections), 10 (23%) with bone/joint infection, and 6 (14%) with bacteremia (Table 2). Most frequently isolated species was A. schaalii (n = 40); followed by 2 cases of A. sanguinis. Susceptibility testing (n = 40) showed that all stains were susceptible to penicillin (MIC< = 0.5), 36% were susceptible to clindamycin (MIC < = 2) and 10% susceptible to metronidazole (MIC < = 8). There was no recurrence of Actinotignum-related infections in any of the treated cases. Two patients with bone/joint infection underwent repeat surgical intervention due to worsening infection while on antibiotic treatment prior to resolution of infection. There was 1 death in a patient with bacteremia (polymicrobial) who had presented with a massive stroke (Table 3). CONCLUSION: A. schaalii was most commonly associated with urinary tract infections followed by abscesses and bone/joint infections in elderly population. Majority of the infections were polymicrobial. All tested isolated were susceptible to penicillin; however, resistance was frequent for clindamycin and metronidazole. All appropriately treated patients had resolution of infection without recurrence from Actinotignum, except for one patient with bacteremia who died from massive stroke [Image: see text] [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809726/ http://dx.doi.org/10.1093/ofid/ofz360.1827 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Syed, Sadia
Sohail, Muhammad R
2147. Human Infections due to Actinotignum Species: A 5-Year Retrospective Review at Mayo Clinic Rochester, Minnesota
title 2147. Human Infections due to Actinotignum Species: A 5-Year Retrospective Review at Mayo Clinic Rochester, Minnesota
title_full 2147. Human Infections due to Actinotignum Species: A 5-Year Retrospective Review at Mayo Clinic Rochester, Minnesota
title_fullStr 2147. Human Infections due to Actinotignum Species: A 5-Year Retrospective Review at Mayo Clinic Rochester, Minnesota
title_full_unstemmed 2147. Human Infections due to Actinotignum Species: A 5-Year Retrospective Review at Mayo Clinic Rochester, Minnesota
title_short 2147. Human Infections due to Actinotignum Species: A 5-Year Retrospective Review at Mayo Clinic Rochester, Minnesota
title_sort 2147. human infections due to actinotignum species: a 5-year retrospective review at mayo clinic rochester, minnesota
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809726/
http://dx.doi.org/10.1093/ofid/ofz360.1827
work_keys_str_mv AT syedsadia 2147humaninfectionsduetoactinotignumspeciesa5yearretrospectivereviewatmayoclinicrochesterminnesota
AT sohailmuhammadr 2147humaninfectionsduetoactinotignumspeciesa5yearretrospectivereviewatmayoclinicrochesterminnesota